Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study [NA]
A single-center randomized pilot study comparing valacyclovir versus valganciclovir for CMV and EBV prophylaxis in kidney transplant recipie…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol
A study protocol investigating CMV and TTV biomarkers in allogeneic hematopoietic stem cell transplant recipients; currently not yet recruit…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
This clinical trial update describes a study of maribavir in adults with kidney failure and CMV infection after transplantation, which is cu…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age [Phase 1, Phase 2]
Update on a Phase 1/2 clinical trial evaluating Moderna's mRNA-1647 vaccine for cytomegalovirus in healthy participants aged 9 to 25, curren…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial in Chinese kidney transplant recipients comparing Leymovir to valganciclovir for prevention of cytomegalovirus infect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies [Phase 2]
Phase II clinical trial evaluating maribavir for cytomegalovirus infection in patients with lymphoid malignancies on bispecific antibodies; …
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND)
A clinical trial investigating whether CMV-specific immune reconstitution after termination of letermovir prophylaxis influences the risk of…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea
This clinical trial update reports that Takeda’s LIVTENCITY (maribavir) is being studied in adults with cytomegalovirus infection after tran…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone [Phase 3]
Phase 3 randomized trial evaluating adoptive family-matched cytotoxic T lymphocytes plus standard of care versus standard of care alone for …
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients [NA]
Clinical trial investigating using cytomegalovirus cell-mediated immunity to optimize the duration of letermovir prophylaxis in hematopoieti…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating cytomegalovirus immune globulin (CMVIG) prophylaxis in belatacept-converted kidney transplant recip…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Study Evaluating the Efficacy and Safety of Artesunate [Phase 2]
This clinical trial update reports a Phase 2 study evaluating the efficacy and safety of artesunate for cytomegalovirus infection, currently…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients [Phase 3]
Phase 3 clinical trial of letermovir (Prevymis) for prevention of cytomegalovirus infection in kidney and pancreas transplant recipients is …
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: A Survey of Maribavir Tablets in Participants With Cytomegalovirus Infection
This update describes a study evaluating maribavir tablets for cytomegalovirus infection, which is currently recruiting participants.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR
A clinical trial update describing a study on monitoring HCMV using PSTM-qPCR after allogeneic hematopoietic stem cell transplantation; the …
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating a multi-antigen CMV-modified vaccinia Ankara vaccine in pediatric patients undergoing donor stem cell…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant [Phase 2, Phase 3]
A Phase 2/3 clinical trial compares valganciclovir with letermovir for CMV prophylaxis in heart transplant recipients and is currently recru…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Evaluation of Software for Interpreting Virological Results Indicated for the Diagnosis of Cytomegalovirus (CMV) Infection During Pregnancy and Intended for Health Professionals
A clinical trial is evaluating software designed to help health professionals interpret virological test results for diagnosing cytomegalovi…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium
Takeda is recruiting adults in Belgium for a study of maribavir to treat post-transplant cytomegalovirus infection.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: A Prospective Single-Arm Observational Study of Maribavir for the Treatment of Post Hematopoietic Stem Cell Transplantation Cytomegalovirus Infection
A prospective, single-arm observational study evaluating maribavir for cytomegalovirus infection after hematopoietic stem cell transplantati…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating virus-specific T-lymphocytes to treat infections with adenovirus, cytomegalovirus, and Epstein-Barr…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. [Phase 1]
Phase 1 clinical trial evaluating TETRAVI Multivirus CTLs to treat EBV, CMV, adenovirus, and BK virus infections in patients after allogenei…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) [Phase 2]
Phase 2 clinical trial evaluating Virus Specific Cytotoxic T-Lymphocytes to treat refractory cytomegalovirus infections in individuals with …
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: R-MVST Cells for Treatment of Viral Infections in Children and Young Adults [Phase 1]
Phase 1 trial evaluating R-MVST Cells for treatment of viral infections in children and young adults is currently recruiting, assessing safe…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT [Phase 2]
Phase 2 clinical trial evaluating CMV-TCIP directed Letermovir prophylaxis after allogeneic stem cell transplantation; recruitment is ongoin…